ArticleEndocrinology and metabolism (Seoul, Korea)2026

Romosozumab and Cardiovascular Safety: Bridging the Gap between Clinical Trials and Real-World Evidence.

Beom-Jun KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.